Sunesis Pharmaceuticals (SNSS) Reports In-Line Q4 EPS

Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.19), in-line with the analyst estimate of ($0.19).

For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Arena Group to rename as Paradium.AI, ticker changing to PAAI
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'